Citius Pharmaceuticals, Inc. Operating Leases, Rent Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Operating Leases, Rent Expense of $2.17 thousand for the 6-month period ending 2016-03-31, per its 10-Q filed 2016-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2016-05-20
- 2016-03-31: Operating Leases, Rent Expense 6 month $2.17K.
| Period end | Operating Leases, Rent Expense 6 month |
|---|---|
| 2016-03-31 | $2.17K 10-Q · filed 2016-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |